Zymeworks Inc (ZYME)
$28.61 -0.35% Close Oct 30, 2026 Live
Zymeworks stock today
Zymeworks closed at $28.61 on October 30, 2026, down 0.35% on the day. Over the past year it returned +49.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.09 billion.
$20.00$25.00$30.00
NovJan 2026MarMayJulSep
| Period | ZYME | S&P 500 (SPY) |
|---|---|---|
| 1 month | +8.0% | -0.9% |
| 3 months | +26.0% | +2.1% |
| Year to date | +8.7% | +11.7% |
| 1 year | +49.6% | +12.4% |
| 3 years | +309.3% | +88.5% |
| 5 years | +28.6% | +76.0% |
Key statistics
- Market value
- $2.09B
- Forward P/E
- 24.1
- Price / sales
- 56.3
- 52-week range
- $16.46 to $31.05
- Next report
- Nov 9, 2026
About Zymeworks
Develops monoclonal antibodies and protein therapeutics for oncology and other diseases.
Sector: Health Care
More on Zymeworks
- Financials: revenue, earnings and segmentsRevenue +39% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $1,286 today
No forecast, no recommendation. This page describes Zymeworks Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.